← All trials
NCT01203488
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 1996
- Primary completion
- Jul 1, 1997
- Completion date
- Jul 1, 1999
- First posted
- —
- Last posted
- —
- Enrollment
- 807
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- National Institute of Child Health and Human Development (NICHD)Lead sponsor
- Yale UniversityOverall official - principal investigator
- Emory UniversityOverall official - principal investigator
- Indiana UniversityOverall official - principal investigator
- Stanford UniversityOverall official - principal investigator
- University of TennesseeOverall official - principal investigator
- Case Western Reserve UniversityOverall official - principal investigator
- George Washington UniversityOverall official - principal investigator
- University of MiamiStudy director
- National Center for Research Resources (NCRR)Collaborator
- Brown UniversityOverall official - principal investigator
- The University of Texas, DallasStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.